Nifty slips as Brent tops $114 and Gift Nifty points lower
Indian equities are under pressure at midday as crude stays hot, Gift Nifty is weak, and Nifty options lean bearish with 22,000 put support and 23,000 call supply.
Why the tape looks like this
Trading - Textile Products leads (+2.51%), Electrodes & Refractories lags
2 of 14 sector groups are positive — narrow leadership, watch the tape.
Options pin the tape at 22,650
PCR 0.69 (call-writer edge), spot 22,417.85. Writers own 22,000–23,000. PCR has moved 0.89 → 0.69 since the open.
Sensex today | Stock Market Live: Sensex drops 500 pts, Nifty slips below 22,500 as Brent crude tops $114
Sensex, Nifty, Share Prices LIVE: Indian equity benchmarks Sensex and Nifty opened higher on Friday but struggled to bui
Options Board
Shift since openPCR
0.89 → 0.69
call-writer edge
Max Pain
22,650
Spot
22,417.85
Put Wall
22,000
support
Call Wall
23,000
resistance
Open interest by strike
as of 12:40 ISTKey Developments
Since the openSensex today | Stock Market Live: Sensex drops 500 pts, Nifty slips below 22,500 as Brent crude tops $114
Why it matters — Sensex, Nifty, Share Prices LIVE: Indian equity benchmarks Sensex and Nifty opened higher on Friday but struggled to bui
Freaky Friday on Dalal Street: Sensex, Nifty reverse morning gains and crash for 3rd session — What's dragging markets?
Why it matters — Indian markets reversed early gains on Friday, with the Sensex and Nifty extending losses for a fourth session. Surging
Sensex Falls 669 Points, Nifty 50 Drops to 22,420 as Oil Prices Surge on West Asia Tensions
Sensex Falls 545 Points, Nifty Sheds 228 Amid Broad-Based Sell | Akashvani News
Q2 Results Live Updates: Infosys, Tata Motors, Adani Power, JSW Steel in focus ahead of earnings today
Moderna Stock Selloff: Why positive cancer vaccine results failed to lift shares
Why it matters — Moderna shares plunged after detailed cancer vaccine trial results triggered profit-taking despite reducing melanoma rec
Sensex, Nifty rebound after 3-day fall on IT stocks buying
Still to Come
Results · macro · corporate actionsMacro & corporate actions
17Educational market commentary only. Not SEBI-registered investment advice.









